ANIP logo

ANI Pharmaceuticals, Inc. (ANIP) Revenue

Annual Revenue:

$614.38M+$127.56M(+26.20%)
December 31, 2024

Summary

  • As of today, ANIP annual revenue is $614.38 million, with the most recent change of +$127.56 million (+26.20%) on December 31, 2024.
  • During the last 3 years, ANIP annual revenue has risen by +$398.24 million (+184.25%).
  • ANIP annual revenue is now at all-time high.

Performance

ANIP Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

Quarterly Revenue:

$227.81M+$16.44M(+7.78%)
September 30, 2025

Summary

  • As of today, ANIP quarterly revenue is $227.81 million, with the most recent change of +$16.44 million (+7.78%) on September 30, 2025.
  • Over the past year, ANIP quarterly revenue has increased by +$79.48 million (+53.58%).
  • ANIP quarterly revenue is now at all-time high.

Performance

ANIP Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

TTM Revenue:

$826.88M+$79.48M(+10.63%)
September 30, 2025

Summary

  • As of today, ANIP TTM revenue is $826.88 million, with the most recent change of +$79.48 million (+10.63%) on September 30, 2025.
  • Over the past year, ANIP TTM revenue has increased by +$271.42 million (+48.87%).
  • ANIP TTM revenue is now at all-time high.

Performance

ANIP TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPincome statement metrics

ANIP Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+26.2%+53.6%+48.9%
3Y3 Years+184.3%+171.8%+192.1%
5Y5 Years+197.4%+330.0%+315.1%

ANIP Revenue Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+184.3%at high+171.8%at high+192.1%
5Y5-Yearat high+197.4%at high+368.5%at high+315.1%
All-TimeAll-Timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

ANIP Revenue History

DateAnnualQuarterlyTTM
Sep 2025
-
$227.81M(+7.8%)
$826.88M(+10.6%)
Jun 2025
-
$211.37M(+7.2%)
$747.40M(+10.9%)
Mar 2025
-
$197.12M(+3.4%)
$674.07M(+9.7%)
Dec 2024
$614.38M(+26.2%)
$190.57M(+28.5%)
$614.38M(+10.6%)
Sep 2024
-
$148.33M(+7.5%)
$555.46M(+3.1%)
Jun 2024
-
$138.04M(+0.4%)
$538.95M(+4.2%)
Mar 2024
-
$137.43M(+4.4%)
$517.46M(+6.3%)
Dec 2023
$486.82M(+53.9%)
$131.65M(-0.1%)
$486.82M(+8.3%)
Sep 2023
-
$131.83M(+13.1%)
$449.39M(+12.0%)
Jun 2023
-
$116.55M(+9.1%)
$401.39M(+11.9%)
Mar 2023
-
$106.79M(+13.3%)
$358.69M(+13.4%)
Dec 2022
$316.38M(+46.4%)
$94.23M(+12.4%)
$316.38M(+11.8%)
Sep 2022
-
$83.82M(+13.5%)
$283.08M(+12.6%)
Jun 2022
-
$73.86M(+14.5%)
$251.32M(+11.2%)
Mar 2022
-
$64.48M(+5.8%)
$226.09M(+4.6%)
Dec 2021
$216.14M(+3.7%)
$60.93M(+17.0%)
$216.14M(+1.7%)
Sep 2021
-
$52.06M(+7.1%)
$212.46M(-0.4%)
Jun 2021
-
$48.63M(-10.8%)
$213.38M(+0.1%)
Mar 2021
-
$54.52M(-4.8%)
$213.22M(+2.3%)
Dec 2020
$208.47M(+0.9%)
$57.25M(+8.1%)
$208.47M(+4.7%)
Sep 2020
-
$52.98M(+9.3%)
$199.19M(+0.8%)
Jun 2020
-
$48.47M(-2.6%)
$197.55M(-2.9%)
Mar 2020
-
$49.77M(+3.8%)
$203.43M(-1.5%)
Dec 2019
$206.55M(+2.5%)
$47.97M(-6.6%)
$206.55M(-4.2%)
Sep 2019
-
$51.34M(-5.6%)
$215.70M(+0.3%)
Jun 2019
-
$54.36M(+2.8%)
$215.07M(+3.4%)
Mar 2019
-
$52.89M(-7.4%)
$207.98M(+3.2%)
Dec 2018
$201.58M(+14.0%)
$57.12M(+12.7%)
$201.58M(+5.1%)
Sep 2018
-
$50.70M(+7.3%)
$191.74M(+1.3%)
Jun 2018
-
$47.27M(+1.7%)
$189.20M(+1.3%)
Mar 2018
-
$46.48M(-1.7%)
$186.70M(+5.6%)
Dec 2017
$176.84M(+37.5%)
$47.29M(-1.8%)
$176.84M(+5.4%)
Sep 2017
-
$48.16M(+7.6%)
$167.76M(+6.1%)
Jun 2017
-
$44.76M(+22.2%)
$158.12M(+9.3%)
Mar 2017
-
$36.63M(-4.1%)
$144.69M(+12.5%)
Dec 2016
$128.62M(+68.5%)
$38.20M(-0.8%)
$128.62M(+18.6%)
Sep 2016
-
$38.52M(+22.9%)
$108.45M(+20.6%)
Jun 2016
-
$31.34M(+52.5%)
$89.90M(+15.1%)
Mar 2016
-
$20.55M(+14.0%)
$78.08M(+2.3%)
Dec 2015
$76.32M(+36.4%)
$18.04M(-9.7%)
$76.32M(-3.8%)
Sep 2015
-
$19.97M(+2.3%)
$79.32M(+3.4%)
Jun 2015
-
$19.52M(+3.8%)
$76.74M(+20.1%)
Mar 2015
-
$18.80M(-10.6%)
$63.87M(+14.1%)
Dec 2014
$55.97M(+86.1%)
$21.04M(+21.0%)
$55.97M(+23.1%)
Sep 2014
-
$17.39M(+161.6%)
$45.47M(+26.6%)
Jun 2014
-
$6.65M(-39.0%)
$35.91M(+1.4%)
Mar 2014
-
$10.90M(+3.5%)
$35.42M(+43.6%)
Dec 2013
$30.08M(+1207.5%)
$10.53M(+34.4%)
$24.66M(+53.2%)
Sep 2013
-
$7.84M(+27.4%)
$16.10M(+92.3%)
Jun 2013
-
$6.15M(+4142.4%)
$8.37M(+259.1%)
Mar 2013
-
$145.00K(-92.6%)
$2.33M(+1.3%)
Dec 2012
$2.30M
$1.97M(+1682.2%)
$2.30M(+414.0%)
Sep 2012
-
$110.40K(+1.5%)
$447.60K(-13.9%)
DateAnnualQuarterlyTTM
Jun 2012
-
$108.80K(-4.6%)
$520.00K(+5.6%)
Mar 2012
-
$114.00K(-0.3%)
$492.20K(+13.1%)
Dec 2011
$435.20K(-82.4%)
$114.40K(-37.4%)
$435.20K(-6.2%)
Sep 2011
-
$182.80K(+125.7%)
$463.80K(+39.6%)
Jun 2011
-
$81.00K(+42.1%)
$332.30K(+32.2%)
Mar 2011
-
$57.00K(-60.1%)
$251.30K(-89.8%)
Dec 2010
$2.47M(+96.7%)
$143.00K(+178.8%)
$2.47M(-27.1%)
Sep 2010
-
$51.30K(>+9900.0%)
$3.40M(+1.2%)
Jun 2010
-
$0.00(-100.0%)
$3.35M(-3.3%)
Mar 2010
-
$2.28M(+114.3%)
$3.47M(+175.8%)
Dec 2009
$1.26M(-66.7%)
$1.06M(>+9900.0%)
$1.26M(-66.9%)
Sep 2009
-
$10.50K(-90.9%)
$3.80M(-1.9%)
Jun 2009
-
$115.20K(+68.4%)
$3.88M(+2.4%)
Mar 2009
-
$68.40K(-98.1%)
$3.79M(+0.1%)
Dec 2008
$3.78M(+666.7%)
$3.61M(+4291.5%)
$3.78M(+655.6%)
Sep 2008
-
$82.20K(+217.4%)
$500.40K(+8.3%)
Jun 2008
-
$25.90K(-58.9%)
$462.00K(-8.6%)
Mar 2008
-
$63.00K(-80.9%)
$505.50K(+2.5%)
Dec 2007
$493.10K(-96.6%)
$329.30K(+651.8%)
$493.10K(-96.5%)
Sep 2007
-
$43.80K(-36.9%)
$14.20M(-0.7%)
Jun 2007
-
$69.40K(+37.2%)
$14.30M(-0.7%)
Mar 2007
-
$50.60K(-99.6%)
$14.40M(-0.2%)
Dec 2006
$14.44M(+5487.7%)
$14.04M(>+9900.0%)
$14.44M(+2627.9%)
Sep 2006
-
$140.30K(-20.0%)
$529.30K(+19.2%)
Jun 2006
-
$175.30K(+107.0%)
$444.10K(+41.3%)
Mar 2006
-
$84.70K(-34.3%)
$314.40K(+21.7%)
Dec 2005
$258.40K(+231.7%)
$129.00K(+134.1%)
$258.40K(+40.3%)
Sep 2005
-
$55.10K(+20.8%)
$184.20K(+31.7%)
Jun 2005
-
$45.60K(+58.9%)
$139.90K(+40.9%)
Mar 2005
-
$28.70K(-47.6%)
$99.30K(+27.5%)
Dec 2004
$77.90K(+18.9%)
$54.80K(+407.4%)
$77.90K(+237.2%)
Sep 2004
-
$10.80K(+116.0%)
$23.10K(+87.8%)
Jun 2004
-
$5000.00(-31.5%)
$12.30K(+68.5%)
Mar 2004
-
$7300.00(>+9900.0%)
$7300.00(-91.3%)
Dec 2003
$65.50K(-97.6%)
$0.00(0.0%)
$84.30K(-95.6%)
Sep 2003
-
$0.00(0.0%)
$1.90M(-33.3%)
Jun 2003
-
$0.00(-100.0%)
$2.85M(0.0%)
Mar 2003
-
$84.30K(-95.4%)
$2.85M(+3.0%)
Dec 2002
$2.77M(+58.5%)
$1.82M(+91.6%)
$2.77M(+191.6%)
Sep 2002
-
$950.00K(>+9900.0%)
$950.00K(-45.6%)
Jun 2002
-
$0.00(0.0%)
$1.75M(0.0%)
Mar 2002
-
$0.00(0.0%)
$1.75M(0.0%)
Dec 2001
$1.75M(>+9900.0%)
$0.00(-100.0%)
$1.75M(0.0%)
Sep 2001
-
$1.75M(>+9900.0%)
$1.75M(>+9900.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2001
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2000
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$0.00(-100.0%)
-
-
Dec 1999
-
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00
$0.00
Dec 1998
$123.10K
-
-

FAQ

  • What is ANI Pharmaceuticals, Inc. annual revenue?
  • What is the all-time high annual revenue for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. annual revenue year-on-year change?
  • What is ANI Pharmaceuticals, Inc. quarterly revenue?
  • What is the all-time high quarterly revenue for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. quarterly revenue year-on-year change?
  • What is ANI Pharmaceuticals, Inc. TTM revenue?
  • What is the all-time high TTM revenue for ANI Pharmaceuticals, Inc.?
  • What is ANI Pharmaceuticals, Inc. TTM revenue year-on-year change?

What is ANI Pharmaceuticals, Inc. annual revenue?

The current annual revenue of ANIP is $614.38M

What is the all-time high annual revenue for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high annual revenue is $614.38M

What is ANI Pharmaceuticals, Inc. annual revenue year-on-year change?

Over the past year, ANIP annual revenue has changed by +$127.56M (+26.20%)

What is ANI Pharmaceuticals, Inc. quarterly revenue?

The current quarterly revenue of ANIP is $227.81M

What is the all-time high quarterly revenue for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high quarterly revenue is $227.81M

What is ANI Pharmaceuticals, Inc. quarterly revenue year-on-year change?

Over the past year, ANIP quarterly revenue has changed by +$79.48M (+53.58%)

What is ANI Pharmaceuticals, Inc. TTM revenue?

The current TTM revenue of ANIP is $826.88M

What is the all-time high TTM revenue for ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals, Inc. all-time high TTM revenue is $826.88M

What is ANI Pharmaceuticals, Inc. TTM revenue year-on-year change?

Over the past year, ANIP TTM revenue has changed by +$271.42M (+48.87%)
On this page